(Q34700869)

4 August 2017

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection (English)

1 reference

4 August 2017

1 reference

1 reference

Peter Hraber

1

0 references

Carla Kuiken

series ordinal

2

object named as

Carla Kuiken

1 reference

4 August 2017

Karina Yusim

3

1 reference

PubMed ID

17935228

4 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

4 August 2017

1 reference

4 August 2017

46

1 reference

4 August 2017

1713-1721

1 reference

4 August 2017

6

1 reference

MHC and the viral hepatitides

4 August 2017

1 reference

Human leukocyte antigen gene polymorphism and the histocompatibility laboratory

21 January 2018

1 reference

In Silico Identification of Supertypes for Class II MHCs

21 January 2018

1 reference

Cell-mediated immunity and the outcome of hepatitis C virus infection

21 January 2018

1 reference

7 January 2021

Protective immunity against hepatitis C virus infection

1 reference

7 January 2021

Immunogenetics of viral infections

1 reference

7 January 2021

Hepatitis C virus and the immune system: a concise review

1 reference

7 January 2021

The evolutionary ecology of the major histocompatibility complex

1 reference

7 January 2021

Description and prediction of peptide-MHC binding: the 'human MHC project'.

1 reference

7 January 2021

Cellular immune selection with hepatitis C virus persistence in humans

1 reference

7 January 2021

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

1 reference

7 January 2021

Heterozygote advantage for HLA class-II type in hepatitis B virus infection

1 reference

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

7 January 2021

The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database

1 reference

7 January 2021

Liver and intestine transplantation in the United States, 1995-2004.

1 reference

7 January 2021

Hepatitis C virus infection: when silence is deception.

1 reference

7 January 2021

A target on the move: innate and adaptive immune escape strategies of hepatitis C virus

1 reference

7 January 2021

Statistical significance for genomewide studies

1 reference

7 January 2021

Host genetic determinants in hepatitis C virus infection

1 reference

7 January 2021

Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection

1 reference

7 January 2021

HLA typing in chronic type B, D and C hepatitis

1 reference

7 January 2021

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

1 reference

7 January 2021

HLA association with hepatitis C virus infection

1 reference

7 January 2021

Human leukocyte antigen phenotypes and hepatitis C viral load

1 reference

7 January 2021

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

1 reference

7 January 2021

HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C

1 reference

7 January 2021

Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation

1 reference

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

7 January 2021

HLA class II genes determine the natural variance of hepatitis C viral load

1 reference

7 January 2021

Higher clearance of hepatitis C virus infection in females compared with males

1 reference

7 January 2021

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

1 reference

7 January 2021

Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach

1 reference

7 January 2021

Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease

1 reference

7 January 2021

HLA-Cw*04 and hepatitis C virus persistence

1 reference

7 January 2021

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

7 January 2021

Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source

1 reference

7 January 2021

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

1 reference

7 January 2021

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

1 reference

7 January 2021

Advantage of rare HLA supertype in HIV disease progression

1 reference

7 January 2021

HIV-1 diversity versus HLA class I polymorphism

1 reference

7 January 2021

Host genetics and viral infections: immunology taught by viruses, virology taught by the immune system

1 reference

7 January 2021

Immunoinformatics comes of age

1 reference

7 January 2021

The Los Alamos hepatitis C sequence database

1 reference

7 January 2021

Hepatitis C databases, principles and utility to researchers.

1 reference

7 January 2021

Los Alamos Hepatitis C Immunology Database

1 reference

7 January 2021

Analytical methods and database design: implications for transplant researchers, 2005

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21889

1 reference

4 August 2017

1 reference

PubMed ID

17935228